Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 443.4B | 490.4B | 454.1B | 478.0B |
| Cost of revenue | 337.6B | 381.4B | 343.6B | 367.0B |
| Gross profit | 105.8B | 109.0B | 110.5B | 111.0B |
| Operating expense | ||||
| Research & development | — | 3.2B | 3.1B | 3.3B |
| Selling general and admin | 99.4B | 52.6B | 53.5B | 53.8B |
| Other operating expenses | — | — | — | — |
| Operating income | 105.8B | 60.7B | 7.3B | 7.1B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 11.2B | 3.2B | 124.7B | 12.3B |
| Tax provision | 1.6B | 7.2B | 31.7B | -1.2B |
| Net income | 9.6B | -4.0B | 93.0B | 13.5B |
| Basic EPS | 578.0 | — | 5.6K | 822 |
| Diluted EPS | 578.0 | — | 5.6K | 822 |
| Basic average shares | — | — | 16.5M | 16.5M |
| Diluted average shares | — | — | 16.5M | 16.5M |
| EBITDA | 105.8B | 198.1B | 26.1B | 25.7B |
| Net income from continuing op. | — | -4.0B | 93.0B | 13.5B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |